tradingkey.logo
搜索

Biote Corp

BTMD
添加自选
2.034USD
+0.044+2.20%
交易中 美东报价延迟15分钟
60.98M总市值
4.04市盈率 TTM

Biote Corp

2.034
+0.044+2.20%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.01%

5天

-3.33%

1月

-3.79%

6月

-21.92%

今年开始到现在

-21.92%

1年

-50.73%

关键数据
2.010今开
2.090最高
10.52K成交量
4.04市盈率 TTM
3.61市盈率动
--股息TTM
0.04%换手率
1.990昨收
2.010最低
20.20K成交额
19.32市盈率静
-1.09市净率
0.00%股息率 TTM
17.36%ROA
4.75052周最高
0.05量比
3.16M净利润
29.99M总股本
0.5031每股收益TTM
1.68Beta
--ROE
1.27052周最低
4.02%振幅
68.88%毛利率
60.98M总市值
-1.84回报/风险
4.04%风险率

TradingKey Biote Corp股票评分

单位: USD 更新时间: 2026-07-01

操作建议

Biote Corp当前公司基本面数据相对稳定,增长潜力较大。当前估值合理,在专业与商业服务行业排名83/162位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价2.99。中期看,股价处于上升通道。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Biote Corp评分

相关信息

行业排名
83 / 162
全市场排名
214 / 4564
所属行业
专业与商业服务

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Biote Corp亮点

亮点风险
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
利润高增长
公司净利润处于行业前列,最新年度总收入192.22M美元
估值合理
公司最新PE估值3.96,处于3年历史合理位
机构减仓
最新机构持股20.55M股,环比减少10.26%
活跃度增加
近期活跃度增加,过去20天平均换手率1.22

分析师目标

根据 5 位分析师
买入
评级
2.986
目标均价
+57.99%
涨幅空间

Biote Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Biote Corp简介

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
公司代码BTMD
公司Biote Corp
CEOChristensen (Bret)
网址https://haymakeracquisition.com/

常见问题

Biote Corp(BTMD)的当前股价是多少?

Biote Corp(BTMD)的当前股价是 1.99。

Biote Corp的股票代码是什么?

Biote Corp的股票代码是BTMD。

Biote Corp股票的52周最高点是多少?

Biote Corp股票的52周最高点是4.75。

Biote Corp股票的52周最低点是多少?

Biote Corp股票的52周最低点是1.27。

Biote Corp的市值是多少?

Biote Corp的市值是74.79M。

现在Biote Corp(BTMD)的股票是买入、持有还是卖出?

根据分析师评级,Biote Corp(BTMD)的总体评级为买入,目标价格为2.99。

Biote Corp(BTMD)股票的每股收益(EPS TTM)是多少

Biote Corp(BTMD)股票的每股收益(EPS TTM)是0.86。